Pediatrix Medical Group, Inc.

NYSE:MD 주식 보고서

시가총액: US$587.8m

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Pediatrix Medical Group 대차 대조표 상태

재무 상태 기준 확인 2/6

Pediatrix Medical Group 의 총 주주 지분은 $856.2M 이고 총 부채는 $709.8M, 이는 부채 대 자기자본 비율을 82.9% 로 가져옵니다. 총자산과 총부채는 각각 $2.2B 및 $1.3B 입니다. Pediatrix Medical Group 의 EBIT는 $152.2M 이며 이자보상배율은 4.2 입니다. $115.5M 의 현금 및 단기 투자금을 보유하고 있습니다.

주요 정보

82.9%

부채 비율

US$709.76m

부채

이자 보상 비율4.2x
현금US$115.47m
주식US$856.20m
총 부채US$1.31b
총 자산US$2.17b

최근 재무 상태 업데이트

Recent updates

Does Pediatrix Medical Group (NYSE:MD) Have A Healthy Balance Sheet?

Jun 19
Does Pediatrix Medical Group (NYSE:MD) Have A Healthy Balance Sheet?

Pediatrix Medical Group (NYSE:MD) Has Some Way To Go To Become A Multi-Bagger

May 10
Pediatrix Medical Group (NYSE:MD) Has Some Way To Go To Become A Multi-Bagger

Pediatrix Medical Group, Inc.'s (NYSE:MD) Price Is Right But Growth Is Lacking

Mar 29
Pediatrix Medical Group, Inc.'s (NYSE:MD) Price Is Right But Growth Is Lacking

Pediatrix Medical Group, Inc.'s (NYSE:MD) Intrinsic Value Is Potentially 100% Above Its Share Price

Jan 10
Pediatrix Medical Group, Inc.'s (NYSE:MD) Intrinsic Value Is Potentially 100% Above Its Share Price

Pediatrix Medical Group, Inc.'s (NYSE:MD) Earnings Are Not Doing Enough For Some Investors

Dec 25
Pediatrix Medical Group, Inc.'s (NYSE:MD) Earnings Are Not Doing Enough For Some Investors

Is Pediatrix Medical Group (NYSE:MD) A Risky Investment?

Nov 14
Is Pediatrix Medical Group (NYSE:MD) A Risky Investment?

Is It Time To Consider Buying Pediatrix Medical Group, Inc. (NYSE:MD)?

Oct 13
Is It Time To Consider Buying Pediatrix Medical Group, Inc. (NYSE:MD)?

Does Pediatrix Medical Group (NYSE:MD) Have A Healthy Balance Sheet?

Aug 09
Does Pediatrix Medical Group (NYSE:MD) Have A Healthy Balance Sheet?

Pediatrix: Unable To Deploy Capital Tied Up In Cash Conversion Cycle, Reiterate Hold

Aug 08

At US$14.21, Is Pediatrix Medical Group, Inc. (NYSE:MD) Worth Looking At Closely?

Jul 03
At US$14.21, Is Pediatrix Medical Group, Inc. (NYSE:MD) Worth Looking At Closely?

The Returns At Pediatrix Medical Group (NYSE:MD) Aren't Growing

Jun 08
The Returns At Pediatrix Medical Group (NYSE:MD) Aren't Growing

Pediatrix Medical Group (NYSE:MD) Has A Somewhat Strained Balance Sheet

Apr 26
Pediatrix Medical Group (NYSE:MD) Has A Somewhat Strained Balance Sheet

Is Now An Opportune Moment To Examine Pediatrix Medical Group, Inc. (NYSE:MD)?

Feb 20
Is Now An Opportune Moment To Examine Pediatrix Medical Group, Inc. (NYSE:MD)?

Pediatrix Medical Group Q4 2022 Earnings Preview

Feb 16

Is Pediatrix Medical Group (NYSE:MD) A Risky Investment?

Jan 12
Is Pediatrix Medical Group (NYSE:MD) A Risky Investment?

Pediatrix: RCM Overhang Now Too Heavy, Revise To Hold

Dec 22

Return Trends At Pediatrix Medical Group (NYSE:MD) Aren't Appealing

Dec 20
Return Trends At Pediatrix Medical Group (NYSE:MD) Aren't Appealing

Pediatrix appoints James Swift as chief executive officer

Dec 15

Why Pediatrix Medical Group, Inc. (NYSE:MD) Could Be Worth Watching

Nov 05
Why Pediatrix Medical Group, Inc. (NYSE:MD) Could Be Worth Watching

Pediatrix Medical Group GAAP EPS of $0.37 misses by $0.11, revenue of $489.92M misses by $21.54M

Nov 03

Pediatrix: These 5 Graphs Suggest It's A Buy

Sep 29

Here's Why Pediatrix Medical Group (NYSE:MD) Can Manage Its Debt Responsibly

Sep 13
Here's Why Pediatrix Medical Group (NYSE:MD) Can Manage Its Debt Responsibly

Here's What To Make Of Pediatrix Medical Group's (NYSE:MD) Decelerating Rates Of Return

Aug 29
Here's What To Make Of Pediatrix Medical Group's (NYSE:MD) Decelerating Rates Of Return

Why Pediatrix Medical Group, Inc. (NYSE:MD) Could Be Worth Watching

Jul 27
Why Pediatrix Medical Group, Inc. (NYSE:MD) Could Be Worth Watching

Pediatrix: Seeking 46% Return Objective As Speculative Buy

Jul 14

MEDNAX, Inc. (NYSE:MD) Shares Could Be 47% Below Their Intrinsic Value Estimate

Jun 24
MEDNAX, Inc. (NYSE:MD) Shares Could Be 47% Below Their Intrinsic Value Estimate

MEDNAX (NYSE:MD) Has A Pretty Healthy Balance Sheet

May 25
MEDNAX (NYSE:MD) Has A Pretty Healthy Balance Sheet

Return Trends At MEDNAX (NYSE:MD) Aren't Appealing

Apr 20
Return Trends At MEDNAX (NYSE:MD) Aren't Appealing

MEDNAX, Inc.'s (NYSE:MD) Intrinsic Value Is Potentially 96% Above Its Share Price

Mar 08
MEDNAX, Inc.'s (NYSE:MD) Intrinsic Value Is Potentially 96% Above Its Share Price

MEDNAX (NYSE:MD) Seems To Use Debt Quite Sensibly

Feb 15
MEDNAX (NYSE:MD) Seems To Use Debt Quite Sensibly

Here's What's Concerning About MEDNAX's (NYSE:MD) Returns On Capital

Jan 19
Here's What's Concerning About MEDNAX's (NYSE:MD) Returns On Capital

Is MEDNAX, Inc. (NYSE:MD) Trading At A 40% Discount?

Nov 17
Is MEDNAX, Inc. (NYSE:MD) Trading At A 40% Discount?

These 4 Measures Indicate That MEDNAX (NYSE:MD) Is Using Debt Reasonably Well

Oct 23
These 4 Measures Indicate That MEDNAX (NYSE:MD) Is Using Debt Reasonably Well

Here's What's Concerning About MEDNAX's (NYSE:MD) Returns On Capital

Oct 08
Here's What's Concerning About MEDNAX's (NYSE:MD) Returns On Capital

Is MEDNAX (NYSE:MD) A Risky Investment?

Jul 19
Is MEDNAX (NYSE:MD) A Risky Investment?

MEDNAX (NYSE:MD) Could Be Struggling To Allocate Capital

Jun 27
MEDNAX (NYSE:MD) Could Be Struggling To Allocate Capital

Statutory Profit Doesn't Reflect How Good MEDNAX's (NYSE:MD) Earnings Are

May 15
Statutory Profit Doesn't Reflect How Good MEDNAX's (NYSE:MD) Earnings Are

Mednax Q1 2021 Earnings Preview

May 06

재무 상태 분석

단기부채: MD 의 단기 자산 ( $426.5M )이 단기 부채( $247.3M ).

장기 부채: MD 의 단기 자산( $426.5M )은 장기 부채( $1.1B ).


부채 대 자본 내역 및 분석

부채 수준: MD 의 순부채 대 자기자본 비율( 69.4% )은 높음으로 간주됩니다.

부채 감소: MD 의 부채 대 자기자본 비율은 지난 5년간 76.2% 에서 82.9% 로 증가했습니다.

부채 범위: MD 의 부채는 영업 현금 흐름 ( 15.9% )에 의해 잘 갚지 않음입니다.

이자 보장: MD 의 부채에 대한 이자 지급EBIT( 4.2 x 적용 범위)로 잘 충당됩니다.


대차 대조표


건강한 기업 발견하기